• No results found

[PDF] Top 20 The Evidence Behind the Treatment of Canine Idiopathic Epilepsy

Has 10000 "The Evidence Behind the Treatment of Canine Idiopathic Epilepsy" found on our website. Below are the top 20 most common "The Evidence Behind the Treatment of Canine Idiopathic Epilepsy".

The Evidence Behind the Treatment of Canine Idiopathic Epilepsy

The Evidence Behind the Treatment of Canine Idiopathic Epilepsy

... Alternative therapies have been also investigated for treating canine epilepsy (including diet trials, nerve stimulation, homeopathic agents), but the results were not very encouraging based on these. ... See full document

38

Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout

Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout

... start treatment fixed at dosages ranging from 50–300 mg/day depending on fac- tors such as renal function, age, and ...no evidence about how often this monitoring should be done, but it makes sense to know ... See full document

12

K-111: the emerging evidence for its potential in the treatment of the metabolic syndrome

K-111: the emerging evidence for its potential in the treatment of the metabolic syndrome

... statins, evidence for the beneficial effects of fibrates on cardiovascular outcomes in patients with the metabolic syndrome is limited to retrospective ...gemibrozil treatment (Manninen et ... See full document

12

Evidence for the role of bevacizumab in the treatment of advanced metastatic breast cancer: a review

Evidence for the role of bevacizumab in the treatment of advanced metastatic breast cancer: a review

... the treatment of metastatic breast ...current evidence for the use of bevacizumab in breast cancer and ongoing studies that address the questions of how to optimize regimens and schedules for the use of ... See full document

8

Dasatinib: the emerging evidence of its potential in the treatment of chronic myeloid leukemia

Dasatinib: the emerging evidence of its potential in the treatment of chronic myeloid leukemia

... new treatment strategies to be developed to override imatinib resistance in ...the treatment of imatinib-resistant ...the treatment of patients with intracranial CML. Preliminary evidence from ... See full document

12

<p>Bracing In The Treatment Of Adolescent Idiopathic Scoliosis: Evidence To Date</p>

<p>Bracing In The Treatment Of Adolescent Idiopathic Scoliosis: Evidence To Date</p>

... successful treatment. This was the fi rst study to provide some very low evidence (Level of Evidence III) for the use of night- time braces in curves above 35 ο during ... See full document

20

&lt;p&gt;An Evidence-Based Review On The Use Of Perampanel For The Treatment Of Focal-Onset Seizures In Pediatric Patients&lt;/p&gt;

<p>An Evidence-Based Review On The Use Of Perampanel For The Treatment Of Focal-Onset Seizures In Pediatric Patients</p>

... the treatment of focal seizures and primary generalized tonic – clonic seizures in children 12 years of age and ...adjunctive treatment for uncontrolled focal-onset seizures, results in an improvement of ... See full document

10

Axitinib: The evidence of its potential in the treatment of advanced thyroid cancer

Axitinib: The evidence of its potential in the treatment of advanced thyroid cancer

... aggressive treatment of this ...for treatment when it becomes ...the treatment of medullary and anaplastic thyroid cancers although the numbers of patients with these subtypes is too small to draw ... See full document

6

Panobinostat for the treatment of multiple myeloma: the evidence to date

Panobinostat for the treatment of multiple myeloma: the evidence to date

... Recently, the results of PANORAMA 1, a randomized placebo-controlled Phase III trial, were published. This was a single largest trial of panobinostat use in multiple myeloma to date, enrolling 768 patients. The ... See full document

8

Profile of nintedanib in the treatment of solid tumors: the evidence to date

Profile of nintedanib in the treatment of solid tumors: the evidence to date

... with evidence of response but at high risk of further early recurrence, patients were randomized to receive either nintedanib 250 mg (n = 43) or placebo (n = 40), bid, continu- ously for 36 ... See full document

11

Galeterone for the treatment of advanced prostate cancer:  the evidence to date

Galeterone for the treatment of advanced prostate cancer: the evidence to date

... Despite the significant success achieved with the next- generation AR-directed therapies, eventually all patients will progress despite these therapies and will ultimately die of progressive metastatic disease. ... See full document

9

Agomelatine: The evidence for its place in the treatment of depression

Agomelatine: The evidence for its place in the treatment of depression

... Introduction: Depressive disorders are among the main causes of disability due to disease. In spite of recent progress in the pharmacotherapy of depression, there is still a high nonresponse rate of ∼30% to the first ... See full document

9

The Evidence Behind the Diagnostic Investigation of Canine Idiopathic Epilepsy

The Evidence Behind the Diagnostic Investigation of Canine Idiopathic Epilepsy

... current evidence available for breeds that have been identified as being predisposed to idiopathic epilepsy with a proven or suspected genetic ...juvenile epilepsy in Lagotto Romagnolo with ... See full document

36

Cognitive dysfunction in naturally occurring canine idiopathic epilepsy

Cognitive dysfunction in naturally occurring canine idiopathic epilepsy

... that idiopathic epilepsy is the most common chronic neurological condition in domestic dogs, with prevalence estimates from ...increasing evidence of neurobehavioural comorbidity in the dog, includ- ... See full document

20

A review of treatment options for behavioural manifestations of clinical anxiety as a comorbidity in dogs with idiopathic epilepsy

A review of treatment options for behavioural manifestations of clinical anxiety as a comorbidity in dogs with idiopathic epilepsy

... In human medicine, TCAs have been shown to have a significantly higher risk of seizures than SSRIs; 1% for clomipramine compared to 0.1% for SSRIs (Ekinci et al., 2009; Kanner, 2016), but evidence of this in ... See full document

35

A randomised trial of a medium-chain TAG diet as treatment for dogs with idiopathic epilepsy

A randomised trial of a medium-chain TAG diet as treatment for dogs with idiopathic epilepsy

... with evidence of enhanced seizure control and an improved side-effects pro fi le in comparison with VPA (52 – 55) ...However, canine and human metabolism of fats and carbohydrates differ, as dogs rely more ... See full document

10

Canine idiopathic chronic hepatitis

Canine idiopathic chronic hepatitis

... of idiopathic CH when there is biopsy evidence of ongoing inflammation and this is associated with mild to moderate ...no evidence for an immune-mediated etiology for canine CH, an ... See full document

32

Risk factors for cluster seizures in canine idiopathic epilepsy

Risk factors for cluster seizures in canine idiopathic epilepsy

... The effect of neuter status and gender of dogs found by Monteiro and others (2012) could not be replicated here, with nearly equal proportions of male and female and neutered and entire dogs experiencing CS. This effect ... See full document

13

Behavioral Interventions as an Adjunctive Treatment for Canine Epilepsy: A Missing Part of the Epilepsy Management Toolkit?

Behavioral Interventions as an Adjunctive Treatment for Canine Epilepsy: A Missing Part of the Epilepsy Management Toolkit?

... for canine idiopathic epilepsy (IE), with an increasing number of AEDs available to veterinarians managing these often challenging patients, a large proportion of this patient population continue to ... See full document

9

International Veterinary Epilepsy Task Force consensus proposal: Medical treatment of canine epilepsy in Europe

International Veterinary Epilepsy Task Force consensus proposal: Medical treatment of canine epilepsy in Europe

... of idiopathic epilepsy is low in all ...focal epilepsy but none of these dogs showed secondary generalisation As the frequency of these focal seizures remained low in these dogs it remains question- ... See full document

28

Show all 10000 documents...